SCHEMBL7353020

SCHEMBL7353020

CS(=O)(=O)NN1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12052674 0.89 TDP1 (0.46)
SCHEMBL4592120 0.88 ALDH1A1 (0.34)
SCHEMBL14697765 0.88
SCHEMBL176589 0.86 CA2 (0.36)
Hydrochloric Acid SCHEMBL11534985 0.84 CA1 (0.35)
SCHEMBL6184435 0.83 RORC (0.31)
SCHEMBL3886688 0.82 PHGDH (0.46)
SCHEMBL15014595 0.80 MEN1 (0.36)
SCHEMBL2918647 0.75
SCHEMBL25623859 0.72 THRA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952328-A MAY BE USED TO ALLEVIATE, MEDIATE, REDUCE AND/OR PREVENT DISORDERS WHICH ARE ASSOCIATED WITH ABNORMAL AND/OR ABERRANT ACTIVITY OF CYSTEINE PROTEASES AND/OR SERINE PROTEASES CEPHALON, INC. (US) 1999-09-14 US disclosed
WO-1991005549-A1 BENZOHETEROCYCLIC COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-05-02 WO disclosed